What disease is shown in
Рис Fig 26?
B.
C.
D.
E.
4.
C.
D.
E.
3.
A. *
E.
2.
A. *
B.
1.
A. *
B.
C.
D.
A. *
B.
C.
D.
E.
5.
A.
B. *
Achalasia of the esophagus
Stomach ulcer
Gastro-esophageal reflux
Ileus
Duodenal ulcer
What is the typical symptom for the disease, which is shown in Рис Fig 26?
Dysphagia
Dysuria
Diarrhea
Constipation
Drive loop
The defeat of which organ is shown in
Esophagus
Stomach
Light
Large intestine
Small intestine
Рис Fig 26?
Which radiological symptom is characteristic for the disease and shown in Рис Fig 27?
Nishi
Focal shadows
Convergence of folds
Index finger
Filling defect
What disease is shown in
Рис Fig 27?
Achalasia of the esophagus
Gastric ulcer

C.
D.
E.
8.
A. *
B.
D.
E.
7.
A. *
B.
C.
D.
E.
6.
A.
B. *
C.
9.
A.
B.
C.
D.
C.
D.
E.
E. *
10.
Gastro – esophageal reflux
Ileus
Duodenal ulcer
The defeat of which organ is shown in Рис Fig 27?
Esophagus
Stomach
Light
Large intestine
Small intestine
What investigation method of the hepatobiliary system is shown in
Рис Fig 28?
Endoscopic retrograde cholangiopancreatography
Ergography
Ultrasonography
Computed tomography
Radiography of the gastrointestinal tract
What kind of pathology reveals diagnostic procedure which is illustrated in
Рис Fig 28?
Pancreat-biliary disease areas
Esophageal disease
Gastric
Disease of the duodenum
Diseases of the Colon
Which radiological symptom is characteristic for the disease shown in
Niche
Focal shadows
Convergence of folds
Index finger
Filling defect
What disease is shown in Рис Fig 29?
Рис Fig 29?

A.
B.
Achalasia of the esophagus
B.
A. *
Stomach ulcer
C.
D. *
Gastro – esophageal reflux
Stomach Cancer
E. Duodenal ulcer
11. X-ray examination result is obtained, shown in
Рис Fig 30. Which method of examination will confirm the diagnosis?
Endoscopy with biopsy
Endoscopy
C. General blood test
D.
C.
Ultrasonography
E.
12.
B. *
Fecal occult blood test
Which radiological symptom is characteristic for the disease, which is shown in Рис Fig 31?
A. *
E.
Nishi
B.
D.
Focal shadows
C.
C.
Convergence of folds
D.
B.
Index finger
E.
A. *
Filling defect
13. X-ray examination result is obtained, shown in
Рис Fig 31. Which method of examination will confirm the diagnosis?
Endoscopy with biopsy
Endoscopy
General blood test
Ultrasonography
Fecal occult blood test
The defeat of which organ is shown in
Рис Fig 31?
14.
A. Esophagus
Antrum
Fundic part of stomach
D. Greater curvature of stomach

E.
15.
Duodenum
Which radiological symptom is characteristic for the disease, which is shown in Рис Fig 32?
A.
A. *
Niche
B.
C.
D.
E.
Focal shadows
Convergence of folds
Index finger
E. * Filling defect
16. X-ray examination result is obtained, shown in
Рис Fig 32. Which method of examination will confirm the diagnosis?
A. * Endoscopy with biopsy
B. Endoscopy
General blood test C.
D. Ultrasonography
Fecal occult blood test
17. Increased abdomen(
Рис Fig 33) is typical for?
Liver cirrhosis complicated by ascites
Obesity B.
C. Hypothyroidism
D. Intestinal obstruction
E. Umbilical hernia
18. For which syndrome of liver cirrhosis are characteristic such changes shown in
Рис Fig 33?
Portal hypertension A. *
B. Hepatocellular failure
Hepatic encephalopathy C.
D. Secondary coagulopathy
E. Secondary anemia
For which disease characteristic is this symptom, shown in
Рис Fig 34?
19.
A. * Cirrhosis

B.
C.
D.
E.
22.
C.
D.
E.
21.
A. *
B.
C.
D.
E.
20.
A. *
B.
E.
23.
A. *
B.
C.
A.
B.
C.
D. *
D.
E.
Obesity
Hypothyroidism
Glomerulonephritis
Pancreatitis
Which symptom of liver cirrhosis is shown in
Рис Fig 34?
Palmar erythema
Contracture Dupiitrena
Gynecomastia
Telangiectasia
Caput medusae
For which disease characteristic is this symptom, shown in Рис Fig 35?
Cirrhosis
Obesity
Hypothyroidism
Glomerulonephritis
Pancreatitis
Which symptom of liver cirrhosis is shown in
Рис Fig 35?
Palmar erythema
Contracture Dupiitrena
Gynecomastia
Telangiectasia
Caput medusa
For which disease characteristic is this symptom, shown in Рис Fig 36?
Cirrhosis
Obesity
Hypothyroidism
Glomerulonephritis
Diabetes

26.
A.
B.
C.
D.
A. *
B.
C.
D.
E.
24.
A.
B.
C. *
D.
E.
25.
C.
D.
E.
28.
A.
B.
C.
D.
E. *
27.
A. *
B.
Which symptom of liver cirrhosis is shown in
Рис Fig 36?
Palmar erythema
Contracture Dyupiitrena
Gynecomastia
Telangiectasia
Caput medusa
For which disease characteristic is this symptom, shown in
Рис Fig 37?
Cirrhosis
Obesity
Hypothyroidism
Glomerulonephritis
Pancreatitis
Which symptom of liver cirrhosis is shown in
Palmar erythema
Contracture Dupiitrena
Gynecomastia
Telangiectasia
Caput medusae
Ultrasound examination of which organ is shown in
Рис Fig 39?
Liver, gall bladder
Kidney
Pancreas
Uterus, the application
Bladder
Peptic ulcer disease
Gastro – esophageal reflux
Stomach cancer
Chronic gastroduodenitis
Рис Fig 37?
What disease are causing microorganisms, which are shown in
Рис Fig 40?

D.
E.
32.
A. *
B.
C.
D.
E. *
31.
A. *
B.
C.
E.
33.
A. *
B.
30.
A.
B.
C.
D.
E. *
29.
A. *
B.
C.
D.
E.
All of the above
What is the activity of microorganisms shown in Рис Fig 40?
Urease
Amylase
Lipase
Lactase
All of the above
What method of discovering microorganisms, which are shown in
Рис Fig 40?
Cytological method
Urease test LIMITED
Histological
Immunological
All of the above
For which disease you prescribe this drug shown in Рис Fig 41?
Biliary dyskinesia
Chronic pyelonephritis
Chronic glomerulonephritis
Chronic bronchitis
All of the above
For which disease you prescribe this drug shown in
Рис Fig 41 (mebeverin)?
Chronic cholecystitis
Chronic cystitis
Rheumatoid arthritis
Microwave
All of the above
For which disease you prescribe this drug shown in Рис Fig 42?
Biliary dyskinesia
Chronic pyelonephritis

36.
A. *
B.
C.
D.
C.
D.
E.
D.
E.
35.
A.
B. *
E.
37.
A. *
B.
C.
D.
E.
38.
C.
D.
E.
34.
A. *
B.
C.
Chronic glomerulonephritis
Chronic bronchitis
All of the above
For relief of which symptom you prescribe drug shown in
Dyspeptic
Dysuria
Diarrheal
Malabsorption
All these
For which disease you prescribe this drug shown in
Рис Fig 43?
Biliary dyskinesia
Chronic pancreatitis
Chronic gastroduodenitis
Duodenal ulcer gastro – esophageal reflux
For relief of which symptom you prescribe drug shown in
Intestinal dyspepsia
Pain
Diarrheal
Malabsorption
All these
Ultrasound examination of which organ is shown in Рис Fig 44?
Liver, gall bladder
Kidney
Pancreas
Uterus, the application
Bladder
Рис Fig 42?
Рис Fig 43?
To the family doctor came patient 22 y.o., complaining of heaviness in the right upper quadrant after

changes in diet, physical activity, bitter taste in the mouth, occasionally nausea. During physical examination in the right upper quadrant is sensitive. Laboratory values within normal limits. Ultrasound examination of abdominal cavity revealed changes shown in
Рис Fig 44. Your diagnosis.
A. * Biliary dyskinesia
B. gastro – esophageal reflux
Chronic pancreatitis C.
D. Cirrhosis
E. Hepatitis
What method of examination is shown in
Рис Fig 45?
39.
A. * Ergography
B.
C.
Colonoscopy
Sigmoidoscopy
D.
C.
Computed tomography
E.
A. *
Ultrasonography
40.
Рис Fig 45 shows data obtained at ergography. Your diagnosis.
Diverticulosis of the colon
B. Cancer of the ascending colon
Cancer of the sigmoid colon
Polyp of sigmoid D.
E. Pathology revealed no
Which part of the stomach is most often affected with gastritis type B (see
Рис Fig 46).
41.
A. * A
B. In
C. C
D. A, B
A, B, C E.
42. Late, night, hunger pain is characteristic for defeat of which organ? (see Рис Fig 47).
A. * 4
B. 1
C. 2

D.
E.
3
5
43. Which radiological symptom is characteristic for the disease and is shown in
Рис Fig 48?
A. * Nishi
B. Focal shadows
C.
D.
Convergence of folds
Index finger
E. Filling defect
44. What disease is shown in
Рис Fig 48?
A. * Peptic ulcer of the lesser curvature of the stomach
B.
C.
Peptic ulcer disease the greater curvature of stomach
Peptic ulcer of the stomach fundus
D.
D.
Stomach cancer
E. Peptic ulcer antral
45. Colonoscopy revealed changes shown in
Рис Fig 49. Your diagnosis.
A. *
B.
A. *
Colon cancer, exophytic growth
Colon cancer, endophytic growth
C.
D.
Diverticulosis
Crohn's Disease
E. NPK
46. Colonoscopy revealed changes shown in Рис Fig 49. What complication is most characteristic for this disease.
Obstructive ileus
Iron deficiency anemia B.
C. B12-deficiency anemia
Gastro-intestinal bleeding
Leukopenia E.
47. What method of investigation is shown in Рис Fig 50?

A. *
A.
Ergography
B. Colonoscopy
C.
D.
Sigmoidoscopy
Computed tomography
E.
48.
B.
Ultrasonography
Рис Fig 50 shows data obtained at ergography. Your diagnosis.
A. Diverticulosis of colon
B. *
C.
C.
Cancer of the ascending colon
Cancer of the sigmoid colon
D. Polyp of sigmoid
E.
A.
No pathology revealed
49.
Er y gography revealed changes of the ascending colon, which are shown in Рис Fig 50. What complication is most characteristic for this disease.
Obstructive ileus
B. * Iron deficiency anemia
B12-deficiency anemia
Gastro-intestinal bleeding D.
E. Leukopenia
The main cause of podpechenochnoy jaundice is defeat of organ, shown in
Рис Fig 47:
50.
A. * 2
3
4 C.
D. 5
1 E.
51. Which symptoms are not typical for the disease, sonographic pattern is depicted in Рис Fig 44:
Vomiting of bile;
Nausea B.
C. Constipation
D. Pain in the right upper quadrant after a fatty meal

C.
D.
E. *
B.
Leukocytosis
52. On ultrasound the patient revealed increased choledochal and intrahepatic bile ducts. What method of investigation shown in Рис Fig 28 is necessary for the diagnosis?
A. Liver biopsy
Endoscopic retrograde cholangiopancreatography
Survey radiography BIO
Ergography
E. Doppler studies of portal system.
Final diagnosis of the disease shown in
Рис 46 Fig require :
53.
A. Serology;
Endoscopy; B.
C. Bacteriological research;
D. * Histological examination of biopsies
E.
54.
40:
Ultrasonography
Which of the following research methods are used to identify the causative agent, shown in Рис Fig
A.
56.
X-ray study;
B.
C.
E.
Scatological study;
Intragastric pH-metry;
D. * Urease breath test
E.
B.
. Ultrasound
55. Patient 54y.o., complained of general weakness, poor appetite, dull pain in the right upper quadrant, bloating, weight loss. Recently there has been intermittent bloody vomiting. Patient malnutrition, icteric sclera, skin dry, raspberry tongue . The following symptoms are shown in
Рис Fig 34, Рис Fig 35, Рис Fig 36, Рис
Fig 37. Your preliminary diagnosis?
A. Steatosis
Chronic hepatitis
Cirrhosis C. *
D. Benign hyperbilirubinemia
Echinococcus of the liver
Male 21 years old, complaining of periodic pain in the abdomen. The examination revealed tenderness

59.
A.
B.
C. in the area 2 shown in
Рис Fig 38. Your preliminary diagnosis?
A. * Antral gastritis
Gastratrophia B.
C. Chronic pancreatitis
D.
E.
B.
Chronic cholecystitis
Chronic colitis
57. For the prophylaxis of the protracted flow of acute bronchitis and intensifying chronic use preparation, represented on Fig 1:
A. paracethamol loratadine
C. sulphalen
D. *
E.
C. bronchomunal codeine phosphate
58. Preparation, represented on Fig 1, is used for the prophylaxis of chronic bronchitis and protracted pneumonia: paracethamol A.
B. loratadine sulphalen bronchomunal D. *
E. codeine phosphate
Fig 2 represents a preparation which is used for treatment of flu, in which the mechanism of action is: an antibiotic
NSAID
Sulphanilamide
Homoeopathic D. *
E. Phythopreparate
60. Homoeopathic preparation, represented in Fig 2, is used for treatment of the following nosology:
Flu A. *
B. Pneumonias

C. bronchial asthma
D.
D. bronchoecthatic illness
E.
61. viral hepatitis
Fig 3 represents a preparation which is used for treatment of flu, with which mechanism of action:
A.
B. by an antibiotic
NSAID
C.
E. sulphanilamide
D. *
E.
D. *
Homoeopathic phythopreparate
62.
A.
Preparation, represented on Fig 3, which is used for treatment of viral diseases, with which mechanism of action: antibiotic
B. NSAID
C. Sulphanilamide
Homoeopathic
Phythopreparate
On the picture in Fig 4 a roentgenologic picture is represents a(n) : 63.
A. Acute bronchitis two-sided hearth pneumonia B.
C. * right-side low-lobular pneumonia pleuropneumonia to bilateral septic pneumonia with abscessing E.
64. The roentgenologic picture of which process is presented on the picture in Fig 4 right-side low-lobular pneumonia A. *
B. bilateral hearth pneumonia
C. acute bronchitis milliary tuberculosis D.
E. to bilateral septic pneumonia with abscessing
65. Fig 5 represents on a preparation which is used for treatment of the followings diseases, except for:

D.
E.
A. flu A and B
B.
C.
acute virus of upper respiratory diseases
C.
D.
B. * viral hepatitis C herpes
E. * diphtheria
66. The inductor of interferonogenesis, in Fig 5 presented on a picture, is used for treatment of the followings diseases, except for:
A. flu A and B diphtheria viral hepatitis C herpes acute virus of upper respiratory diseases
67.
A.
Fig 6 represents on a preparation which is used for treatment of the following diseases, except for:
A.
B. flu A and B acute virus of upper respiratory diseases
C.
D. * viral hepatitis C diphtheria
E.
B. radiculitis
68.
A. *
On the picture in Fig 6 preparation-inductor of interferonogenesis is presented, that is used for treatment of the following diseases, except for: diphtheria acute virus of upper respiratory diseases viral hepatitis C; C.
D. flu A and D radiculitis E.
69. Fig 7 represents a preparation which is used for treatment of the following diseases, except for: flu A and B
acute virus of upper respiratory diseases B.
C. viral hepatitis C

A.
B.
C. *
D.
E.
D.
E.
72.
E.
71.
A.
B.
C. *
E.
74.
A.
73.
A.
B. *
C.
D.
A.
B.
C. *
D.
D.
E. *
70. for: herpes poliomyelitis
In Fig 7 the preparation which is used for treatment of the followings diseases is represented, except flu A and B
acute virus of upper respiratory diseases poliomyelitis herpes viral hepatitis C
Fig 8 represents a preparation which is used for treatment of the following diseases, except for: flu A and B acute virus of upper respiratory diseases viral hepatitis herpes adenovirus viral hepatitis C flu A and
В
С
Fig 8 represents a preparation which belongs to the following group:
Vitamin
Antibiotic inductor of interferonogenesis fetopreparation homoeopathic
Fig 9 represents a preparation which is used for treatment of the following disease: measles viral hepatitis D herpes
Fig 9 represents a preparation which is used in complex treatment in the following disease: viral hepatitis C

C. *
D.
E.
77.
A.
D.
E.
76.
A.
B.
75.
A.
B.
C. *
B.
C.
D.
E. *
E. *
78.
A. *
B.
C.
B.
C.
D.
D.
E. herpes measles viral hepatitis D flu A and
В
Fig 9 represents a preparation which belongs to the following group: vitamin antibiotic inductor of interferonogenesis fetopreparate homoeopathic
Which disease the two projection x-ray shows in Fig 10 : acute bronchitis bilateral lobar pneumonia right-side low-lobular pneumonia pleuropneumonia bilateral septic pneumonia with abscessing
A roentgenologic picture in two projections shows which process in Fig 10: acute bronchitis bilateral lobar pneumonia bilateral septic pneumonia with abscessing pleuropneumonia right-side low-lobular pneumonia
What nosology is represented in Fig.10: right-side low-lobular pneumonia left-side hearth pneumonia bilateral septic pneumonia pleuropneumonia chronic bronchitis

81.
A. *
B.
C.
D.
A. *
B.
C.
D.
E.
E.
82.
A. *
B.
79.
A.
B.
C.
D.
E. *
80.
C.
D.
E.
83.
A.
B.
C.
Fig 11 represents a preparation which is used for treatment of the following disease: acute virus of upper respiratory tract viral hepatitis C viral hepatitis D genital herpes flu A and
В
Fig 11 represents a preparation which is used for treatment of the following disease: flu A and
В viral hepatitis C viral hepatitis B leptospirosis acute virus of upper respiratory diseases
Which investigation needs to be done in order to prove the diagnosis of oral cavity disease in Fig 12:
Test for diphtheria agent
X-ray of chest general analysis of blood general analysis of urine biochemical blood test
Which investigation needs to be done in order to prove the diagnosis of oral cavity disease in Fig 12:
Test for diphtheria agent
X-ray of chest general analysis of blood general analysis of urine biochemical blood test
To which group of preparation, the drug represented in Fig 3, belongs to: hepatoprotector intestinal antiseptic inductor of interferonogenesis

D.
E.
86.
A.
B.
E.
85.
A. *
B.
C.
D. *
E.
84.
A.
B.
C.
D. *
A. *
B.
C.
D.
E.
C.
D.
E. *
87.
88.
A.
B. * antivirus fetopreparate
The preparation demonstrated in Fig 1 is used to treat all of the following conditions except for: prophylaxis of chronic bronchitis protracted pneumonia prophylaxis of COPD treatment of infiltrative tuberculosis protracted course of acute bronchitis
Fig 13 represents a preparation which is used for treatment of the following disease: acute virus of upper respiratory tract viral hepatitis C viral hepatitis B genital herpes papillomatosis
The preparation in Fig 13 represents which treatment of the followings nosologies: papillomatosis viral hepatitis C viral hepatitis B genital herpes acute virus of upper respiratory tract
Fig 14 represents a preparation which is used for treatment of all infections, except for: acute virus of upper respiratory tract viral hepatitis C viral hepatitis B genital herpes papillomatosis
Fig 14 represents a preparation which belongs to the following group:
Antibiotics antiviral preparations

C.
D. vitamins antichlamidial preparations
E. antimalarial preparations
89. The following diagnosis shown in sciagram in Fig 15 is:
A. acute bronchitis
B.
C.
D. *
E. bilateral lobar pneumonia milliary tuberculosis right-side croupose medium-lobular pneumonia bilateral septic pneumonia with abscess
90.
A. *
The radiograph, in Fig 15 represents x-ray showing the following process: right-side croupose medium-lobular pneumonia
B. bilateral pneumonia
C.
D. left-side hearth pneumonia chronic bronchitis
E.
91. bilateral septic pneumonia with abscessing
In which department shown in Fig 16, patients with acute form of pneumonia are treated ?
A. Cardiology
B.
C.
Phthysiathrics
Surgical
D. *
E.
C.
Resuscitation( ICU) nephrologicyl
92. Treatment of heavy form of pneumonia must be conducted in the following in the following department (shown in Fig 16): at home A.
B. outpatient department pulmonological department in a therapeutic department D.
E. * in resuscitation (ICU) department

93.
95.
The following diagnosis is verified on a sciagram (Fig 17) :
A. acute bronchitis
B.
C.
C. bilateral hearth pneumonia milliary tuberculosis
D. *
E.
B. right-side croupose upper-lobular pneumonia bilateral septic pneumonia with abscessing
94. On the sciagram (Fig 17) a pathological process is presented in the broncho-pulmonary system with localization in :
A. * left-side croupose pneumonia bilateral hearth pneumonia left-side infiltrative tuberculosis right-side croupose upper-lobular pneumonia D. *
E. bilateral septic pneumonia with abscessing
In Fig 18 the roentgenologic picture represents :
A. acute bronchitis
B. bilateral hearth pneumonia milliary tuberculosis C.
D. pleuropneumonia bilateral septic pneumonia with abscess E. *
96. The roentgenologic picture of what nosology process is presented in Fig 18:
A. * bilateral septic pneumonia with abscess bilateral hearth pneumonia B.
C. left-side infiltrative tuberculosis pleuropneumonia D.
E. chronic bronchitis
Fig 19 represents one of methods used for diseases verification of the broncho-pulmonary system: 97.
A. * thermography of chest
B. ECG
C. US CG

D.
E.
C. fonoCG chest X-ray
98. One of methods used in establishment of the inflammatory diseases of the broncho-pulmonary system is shown in Fig 19: general analysis of blood A.
B. ECG
US CG
Thermography of chest D. *
E. chest X-ray
Which disease is represented on the x-ray in Fig 20: 99.
A. Acute bronchitis
B. * bilateral pneumonia milliary tuberculosis C.
D. pleuropneumonia peripheral cancer of lights E.
100. The roentgenologic picture of what disease is shown in Fig 20:
A. Acute bronchitis peripheral cancer of lights B.
C. left-side infiltrative tuberculosis pleuropneumonia D.
E. * bilateral pneumonia
101. In Fig 21 the roentgenologic picture represents :
A. Acute bronchitis
B. * pneumonia milliary tuberculosis C.
D. pleuropneumonia
E. peripheral cancer
102. The roentgenologic picture of what process is presented on Fig 21:
A. chronic bronchitis

B.
C. peripheral cancer milliary tuberculosis
D. pleuropneumonia
E. * pneumonia
103. In Fig 22 the roentgenologic picture represents :
A.
B. acute bronchitis
Pneumoconiosis
C.
D. milliary tuberculosis
D. *
C. pneumonia
E. peripheral cancer
104.
A.
The roentgenologic picture of what nosology is represented in Fig 22: chronic obstructive bronchitis
B. * pneumonia
C.
D.
E.
C. cavernous tuberculosis bronchial asthma peripheral cancer
105. For treatment of post-influenzal pneumonia which of the following antibiotic preparation is most frequently used, see Fig 23:
A. * Augmentin
B. Penicillin
Sulfalen
Erythromycin D.
E. Rifampicin
On Fig 23 preparation which is represented for treatment of disease which arises as a complication of 106. flu: post-influenzal pneumonia A. *
B. bronchial asthma chronic hepatitis
Pneumoconiosis

E.
107.
Tuberculosis
The roentgenologic picture of what nosology is represented in Fig 24:
A. * chronic obstructive bronchitis with infiltration of lung roots
B. bilateral pneumonia
C. cavernous tuberculosis
D.
E. bronchial asthma peripheral cancer
108. Fig 24 represents a radiograph of the following disease:
A. peripheral cancer
B. bilateral pneumonia
C.
D. cavernous tuberculosis bronchial asthma
E. * chronic obstructive bronchitis with infiltration of lung roots
109. In Fig 25 the roentgenologic picture represents :
A. acute bronchitis
B.
C. tuberculoma milliary tuberculosis
D. *
E. pleuropneumonia peripheral cancer
110. The x-ray picture in Fig 25 shows which disease?:
A.
B. * chronic bronchitis pleuropneumonia
C.
D. cavernous tuberculosis tuberculoma
E.
B. central cancer
111.
A. *
To which group the following antibacterial preparates, that are used for treatment of pneumonia shown in Fig 23, belong to,: protected aminopenicillins aminopenicillins

C.
D. sulfanilamides macrolides
E.
112. cefalosporines
Fig 25 illustrates x-ray of the following disease:
A.
B. chronic bronchitis tuberculoma
C. cavernous tuberculosis
D. * pleuropneumonia
E.
A. * central cancer
113.
A patient came into the doctor’s office complaining of shortness of breath, decreased physical activity, edema of the legs, recurrent pain in chest, heaviness in the right upper quadrant. On examination marked yellow - pale face with cyanotic crimson-tinge, see Fig 53. What is happening to the patient?
Face
Сorvisart
Thyrotoxic face B.
C. Acromegalic face
D.
E.
Mixedematous face
Hippocratic face
114. Patient V., 47 y.o., throughout the year complained of chest pain, dull in nature, which is not eleviated by the drug shown in Fig 59. On the ECG: visible changes caused by previous myocardial infarction. What is the likely cause of these complaints?
A. * Development of tolerance to nitrates
Development of unstable angina B.
C. Recurrence of myocardial infarction
D. Development of re-infarction
E. Not adequate dose of nitrates
115. Patient 55 y.o. complains of chest pain dull in nature while walking up to 100 meters, up to 15 minutes, the feeling of not enough air, and sweating. Objective: increased borders of the heart are shown in Fig 72, heart tones are muffled, rhythmic, HR-90 min, BP-140/90 mmHg. During last week the pain has been appearing at night when patient was calm. The pain has disappeared after taking one tablet of nitroglycerin. On ECG: high peaked T wave in V2-V4 leads. What disease you can think of?
A. * Progressive angina
B. Stable angina FC IV

C.
D.
Myocardial infarction
Spontaneous Prinzmetal angina
E. Stable angina III FC
116. A patient with mitral heart defect with predominance of mitral valve insufficiency, complained of gradually appearing weakness, severe shortness of breath. OBJECTIVELY: acrocyanosis, moist rales in the lower parts of the lungs, expanding the borders of the heart, the changes are shown in Fig 51. These features indicate evidence of development of:
A. * Chronic heart failure
B.
C.
Chronic vascular insufficiency
Acute heart failure
D. Pneumonia
E.
117.
Pericardial effusion
A woman, 68 years old, 7 days ago, experienced a sudden onset of pain in the left half of the chest, and shortness of breath. OBJECTIVELY: cyanosis, distention of neck veins, changes are shown in Fig 60, pulse -
100/min, BP - 110/70 mm Hg, BR - 24/min. Above the lungs on the left side below the scapula dullness is hear upon percussion, loud moist wheezing sounds are heard, expanded borders of the heart to the right, accent of II tone on the pulmonary artery is noted. Liver +4 cm, patient’s left leg is swollen, sharply painful on palpation.
On the ECG: the deep tones of S in I and aVL, Q in III and aVF leads, negative T in III, aVF leads. The above-described symptoms are most typical for:
A. Myocardial infarction
Exudative pleuritis B.
C. * Pulmonary heart disease
D. Dry pericarditis
E. Pneumonia
118. Patient 45 years old with myocardial infarction, in the anterior wall of the left ventricle felt "fading" of the heart, increased fatigue, heart rate 78 per min. On ECG: changes are reflected in Fig 63. What is the complication of myocardial infarction which occured?
A. * Ventricular premature beats
Atrial extrasystole B.
C. Nodal extrasystole
D. Ventricular tachycardia
E. Intraventricular blockade
119. In an 18 years old athlete, the Holter monitoring revealed changes which are shown in Fig 64.
Complaints and changes in the internal organs are absent. What is the best tactics of the patient.

A. *
B.
No treatment
A course Riboxin
C. Prescribe belataminal
D.
B.
Prescribe verapamil per os
E.
A. *
Prescribe tincture of hawthorn
120. Patient 42 years old with combined mitral valve defect complained of shortness of breath with minimal exertion. On examination revealed the changes which are shown in Fig 52. The appearance of these signs indicates the development of:
Chronic heart failure.
Chronic vascular insufficiency
C. Acute heart failure
D.
E.
Pneumonia.
Pericardial effusion
121. A 42 years old patient suffered in childhood from rheumatic fever. Regularly undergoing treatment.
Objective examination: relative borders of cardiac dullness are shown in Fig 73, the apex beat is stronger, systolic murmur in the second intracostal space is heard and the right side of the sternum, in the same place the weakening of the second tone of the heart, and systolic murmur in the II intercostal space in the right side of the sternum. The patient most likely has:
A. * Aortic stenosis
B. Stenosis of the left atrioventricular opening
Mitral insufficiency C.
D. Complex mitral defect
E. Aortic valve insufficiency
122. Patients 19 years old, has been suffering from rheumatism for the past 5 years. During medical examination expansion of the borders of the heart was revealed, see Fig 72; weakening of I tone, systolic murmur over the apex, which irradiates in the left axillary area, the accent of II tone on the pulmonary artery.
What kind of acquired heart disease is present?
Mitral insufficiency A. *
B. Stenosis of the left atrioventricular opening
C. Aortic valve
Aortic stenosis D.
E. Tricuspid regurgitation

123. A 49 years old man was diagnosed with angina II functional class. The drug illustrated in Fig 56 causes severe headache. Which of the above drugs can be used to relieve angina pectoris?
A. * Molsidomine (sidnofarm)
B. Amiodarone (Cordarone)
C. Nifedipine (corinfar)
D. Propranolol (obzidan)
E. Verapamil (finoptin)
124. A 57 years old man presented to the dispensary because of IHD: Stenocardia voltage from 5 years ago.
He went to see his family doctor because for the last 2 weeks angina symptoms occured more frequently with less stress and physical loading. On the ECG: changes are shown in Fig 62 Objectively: Borders of the heart extended to the left, the tones are muted, HR = Pulse = 76 per minute, BP= 160/90 mmHg. What should be done for the patient?
A. * Emergency Hospitalization
Routine admission B.
C. Undertake complementary studies
D. To continue outpatient treatment
E. Consultation cardiologists
125. A 57 years old man within the last year while walking up to 500 m experienced anginal attacks . There are no others complaints. Objectively: expanded borders of the heart to the left + 1 cm, the tones are muted, HR
= 78 for 1 min, BP 140 /80 mm Hg. The electrocardiogram revealed changes, see Figure 62. The best treatment plan for this patient is
A. * Hospitalization
B. Outpatient care
C.
D.
Physical training
Spa treatment
E. Low-calorie diet
126. A patient, 53 years old, complaining of severe retrosternal pain, which irradiates to the left arm and left shoulder. The pain lasts for about 3 hours. A history of peptic ulcer, cholelithiasis, chronic thrombophlebitis of lower extremities is noted. OBJECTIVELY: pale, a weak pulse 120 beats per minute. BP 90/70 mm Hg. Heart sounds are muffled: the ECG revealed changes which are shown in Fig 67. Blood test: Hb - 134 g / l, white blood cells - 10,4 g / l, ESR 20 mm / h. your diagnosis.
A. * Acute myocardial infarction
B. Penetration of gastric ulcers
C. Exacerbation of chronic pancreatitis
D. Intercostal neuralgia

E. Pulmonary embolism
127. Male 42 years old was taken to the hospital with complaints of crushing and burning pain in the heart area radiating to the left shoulder, shortness of breaths and severe weakness. Pain syndrome arose first time in his life after an emotional stress, lasting about an hour. Objectively: Ps - 98/min, rhythmic. BP - 130/80 mmHg.
Heart sounds are muffled, murmurs are absent. Electrocardiogram revealed changes shown in Fig 68. What is the most accurate diagnosis:
Anterior myocardial infarction A. *
B. Angina
C. Unstable angina
D.
E.
D.
Extensive myocardial infarction
Transmural myocardial infarction
128.
A.
A patient, 45 years old, with acute myocardial infarction on ECG revealed changes which are shown in Fig 69. What is the localization of the areas of necrosis?
Anterolateral
B. Posterior membranous
C. * Posteriordiaphragmatic with the transition to the side
Front spread
E.
A. *
Anterior
129. Patient 45 years old with myocardial infarction in the anterior left ventricular wall, he felt "fading" of the heart, increased weakness, ECG changes are shown in Fig 65. What is the complication of myocardial infarction which occurs in the patient?
Ventricular premature beats
B. Atrial extrasistole
C. Nodal extrasystole
D.
E.
D.
Ventricular tachycardia
Intraventricular blockade
130.
A. *
A man, who is in the ICU for acute myocardial infarction (first day) ECG shows extrasystoles see Fig
62. In this situation, which drug should be given .
Lidocaine
B. Novokainamid
C. Cordarone
Verapamil

E. Ethacyzin
131. A 57 years old man was brought to the emergency department with complaints of burning chest pain, feeling short of breath and general weakness. OBJECTIVELY: over the lungs vesicular breathing and in the lower parts moist rales. Respiratory rate rate 24 breaths a min. Muffled heart sounds, heart rate = 98 for 1 min,
BP 120/80 mmHg. See ECG in Fig 69. Treatment should begin with an introduction of:
Morphine A. *
B. Heparin
C. Inderal
D.
E.
Polarizing mixture
Streptaza
132. Patient 42 y.o. complains of severe burning pain behind the breastbone, which arose about an hour ago after physical overload, cold sweat, general weakness. Objectively: The skin is clear, pale color. Pulse - 72 bpm, BP - 190/100 mm Hg The borders of the heart have not changed. Sounds are relaxed and clear. The results of the ECG shown in Fig 69. What is the localization of myocardial infarction?
A. * Posterodiaphragmal
B. Basal
C. Antero – lateral
D.
E.
Circular
Forward-webbed
133. The patient of 72 years with acute myocardial infarction with ECG changes shown in Fig 70. At the same time, the patient developed acute ventricular failure. BP - 90/50 mm Hg. What is the most effective and safe treatment for this patient?
A. * Antishock
Novokainamid B.
C. Lidocaine
D. Cordarone
E. Meksitil
134. Patient 58 y.o.brought to the emergency department with pain on the left side of chest. On clinical examination, except for tachycardia (heart rate - 102/min), abnormalities were not found. See the ECG image in Fig 68. What is the most likely diagnosis?
A. * Acute myocardial infarction of anterior wall of the left ventricle
B. Angina
C. Aortic dissection

D.
E.
C.
Pulmonary embolism
Pericardial effusion
135. A patient, present in the dispensary because of IHD, with clinical signs shown in Fig 51, treatment should begin with?
Veroshpiron (spironolactone) A. *
B. Nitroglycerin
Nifidfpinu
Riboxin D.
E. Thiotriazoline
Which drug can cause symptoms which are shown in Fig 51? 136.
A. Diclofenac
B. Prednisolone
Nifidipin C.
D. Betamethasone
In all of these cases E. *
137. Preparations shown in Fig 58 can be combined with:
A. * Calcium antagonists and propranolol
Rauwolfia B.
C. Calcium supplementation
Calcium antagonists D.
E. Propranolol
138. Preparations shown in Fig 58 cannot be combined with:
A. * Calcium supplementation
B. Spironolactone
Potassium preparations C.
D. Enalapril
E. Hydralazine
139. The most frequent cause of changes in the borders of relative heart dullness (see Fig 72) is:
A. * Mitral stenosis

A. *
B.
C.
D.
E.
143.
A.
B.
C.
D.
E.
142.
B.
C.
D.
E. *
C.
D.
E.
141.
A. *
140.
A. *
B.
B.
C.
D.
E.
Pulmonary embolism
Primary pulmonary hypertension
Congenital heart defects with hypervolemia of the pulmonary circulation
Left ventricular failure
In the disease, shown in Figure 52 in urine are present all these changes, except for:
High-sodium
Albuminuria, which is often repeated
High specific gravity of urine
The presence of hyaline cylinders
Periodic appearance of erythrocytes
One way to treat the symptoms of heart failure, as shown in Fig 51:
All these methods
Increase doses of diuretics
Correction of plasma protein spectrum
Restriction of fluid intake and salt
Accession aldosterone antagonists
In which of these situations drugs of this group are contraindicated, see Fig 58?
Frequent ventricular premature beats in sinus brady-arrhythmia
Paroxysmal supraventricular tachycardia
Circulatory failure in combination with atrial fibrillation
Acute right ventricular failure
In all of these cases
In which of these situations these drugs are contraindicated, seeFig 61:
Anuria;
Acute renal failure;
Chronic renal failure with a significant decline in function;
Hyperkalemia
In all these cases

144.
A. *
With an overdose of the drug, shown in Figure 52 Fig which drugs should be given:
Potassium unitiol
B.
A. *
Holistiramin
C. Atropine
D. Calcium
E. Adrenaline
145. During physical examination, changes in borders of relative cardiac dullness were noted, see Fig 73, which echocardiographic characteristics are not typical for this pathology?
Left atrium dilatation
B.
C.
A.
Semi closing of the aortic valve leaflets in diastole
Diastolic flutter of the anterior mitral valve
D. Eccentric left ventricular hypertrophy
E. Reverse flow in the abdominal aorta in diastole
146. Which of the following is not the cause of the disease which are shown by the main manifestations shown in Fig 52:
NDC
B.
C.
Coronary heart disease
Arterial hypertension
D.
B.
Heart defects
E.
147.
Secondary cardiomyopathy
A. *
Objective examination of the borders of heart dullness identified changes which are shown in Fig 72.
What auscultative symptoms are not typical for this pathology?:
The weakening of tone I
Popping in tone I at the top
Diastolic murmur at the apex of the heart C.
D. Diastolic feline murmurs on the apex
E. The tone of the opening of the mitral valve
148.
A. *
Objective examination of the borders of cardiac dullness, revealed changes which are shown in Fig 72.
Which direct auscultative symptoms are typical for this pathology?
Systolic murmur at the apex of the heart, coupled with the weakening of tone I

B.
C.
Displacement of the upper border of the heart up
Accent II tone on pulmonary artery
D. Strengthen and tone, the tone of the opening of the mitral valve, diastolic murmur at the apex
E.
A. *
Right ventricular hypertrophy
149. Drug of choice for the treatment of arrhythmias identified in Fig 62 BN patients with dilational cardiomyopathy are:
Cordarone
Disopyramide B.
C. Verapamil
Beta-blockers D.
E. Novokainamid
150. In extrasystoles seen in Fig 66 does not include:
A. *
B.
A. *
Basal
Atrial
C.
D.
With the A-V compounds (knots)
Sinuses
E. Stem
151. On examination the patient received the ECG results which are shown in Fig 70. The family doctor used a Danini-Ashner technique . What is its essence?
Massages eyeballs
B.
A. *
Any breath-holding
C.
D.
Hold breath on inspiration
Carotid sinus massage
E. Set ups
152.
On physical examination, changes of the borders of relative cardiac dullness are noted, see Fig 73, which radiographic signs are not typical for this pathology? significant increase in the left atrium
B. normal size heart
C. poststenosal enlargement of the aorta
D. apex protrusion of the left ventricle

E.
153. all characterized
Which syndrome of decrease of function in anatomical structure shown by number 1 in Fig 74:
A. * all of these options
B. severe sinus bradycardia
C. sinus arrest
D. syndrome tachycardia-bradycardia
E.
154. sino-atrial block
The patient is being treated for reoccurrence of myocardial infarction of the left ventricular posterior wall. Complaints of pain in the heart, and arrhythmia were observed. On the ECG frequency of atrial contractions 76, ventricular, 36, RR intervals and RR - the same. At which level of the heart conduction system
(see schematic diagram in Fig 74) is present violation?
A. * 6
1 B.
C. 2
D. 4
E.
A. *
5
155. Look at the schematic representation of heart disease represented in Fig 54, from which medication you should start treatment?
Nitrosorbit
Riboxin B.
C. Trental
D.
E.
C.
Nifidipinu
Clonidine
156. Look at the schematic representation of heart disease represented in Fig 54 from which of the drug you should start treatment? morphine A. *
B. Riboxin
Trental
Nifidipinu D.
E. Clonidine

157. Look at the schematic representation of heart disease represented in Fig 54 B, from which preparation you should start treatment?
A. * Morphine
B. Riboxin
C. Trental
D. Nifidipinu
Clonidine E.
158. Contraindication to the drug shown in Fig 57 is:
A. * All of the above
B. Cardiogenic shock
C. Hypotension
D.
E.
Collapse
Reduced end-diastolic pressure in the left ventricle
159. Contraindication to the drug shown in Fig 59 is:
A. * All of the above
C.
D.
E.
B. Cardiogenic shock
C.
D.
B.
Hypotension
Collapse
E. Reduced end-diastolic pressure in the left ventricle
160. The drug which is presented in Figure 57 Fig is prescribed when present intolerance of which drugs from the following groups:
A. * Nitrates
Calcium antagonists
ACE inhibitors
Beta blockers
Non steroid anti-inflammatory
161. What is demonstrated on the schematic representation of the heart conduction system in Fig 55 marked by number 1:
A. * Sinus node,
B. Atrioventricular node

C.
D.
Common trunk of atrioventricular bundle,
Bundle branch block,
E. The system of Purkinje fibers.
162. The schematic representation of the heart conduction system in Figure 55 № 3 shows:
A. * Atrioventricular node,
B.
C.
Sinus node,
Common trunk of atrioventricular bundle,
D. Bundle branch block,
E. The system of Purkinje fibers.
163. The schematic representation of the heart conduction system in Figure 55 № 4 shows:
A. *
B.
Common trunk of atrioventricular bundle,
Sinus node,
C. Atrioventricular node
D. Bundle branch block,
E. The system of Purkinje fibers.
164.
A. *
The schematic representation of the heart conduction system in Figure 55 Fig № 6 shows:
Bundle branch block,
B.
C.
Sinus node,
Atrioventricular node
D. Common trunk of atrioventricular bundle,
E. The system of Purkinje fibers.
165. The patient, 53 years old complaining of severe retrosternal pain, which irradiates to the left arm and left shoulder. The pain lasts for about 3 hours. A history of peptic ulcer, cholelithiasis, and chronic thrombophlebitis of lower extremities are noted. OBJECTIVELY: pale, weak pulse 88 beats a minute. BP
90/70 mm Hg. Heart sounds are muffled. The electrocardiogram reveals changes seen in Fig 67. Blood test: Hb
- 134 g / l, white blood cells - 10,4 g / l, ESR 20 mm / h. From which drug you should start treatment?
A. * Morphine
Riboxin B.
C. Trental
D. Nifidipinu

E. Clonidine
166. Patient 73 y.o. complains severe retrosternal pain, which irradiates to the left arm and left shoulder. The pain lasts for about 3 hours. A history of chronic thrombophlebitis of lower extremities. OBJECTIVELY: acrocyanosis, a weak pulse 92 beats a minute. BP 90/70 mm Hg. Heart sounds are muffled. ECG reveals changes seen in Fig 68. Blood test: Hb - 134 g / l, white blood cells - 10,4 g / l, ESR 20 mm / h. From which drug you should start treatment? nitroglycerin A. *
B. Riboxin
C. Trental
D.
E.
Nifidipinu
Clonidine
167. To the family doctor came patient 54 y.o. complaining of severe retrosternal pain, which irradiates to the left arm, and left shoulder. The pain lasts for about 4 hours. OBJECTIVELY: acrocyanosis, weak pulse 92 beats a minute. BP 110/70 mm Hg. Heart sounds are muffled. ECG reveals changes seen in Fig 68. |What should be the tactics of the family doctor?
A. * Emergency Hospitalization
Routine admission B.
C. Undertake complementary studies
D.
E.
Continue as an outpatient treatment
Consult a cardiologists
168.
C.
Which symptoms characterize the disease shown in. Fig 76?
A. *
B.
Spontaneous pain that increases with all movements, joint gap narrowing, osteoporosis of epiphysis, erosion of articular surfaces
Absence of deformations in joints
Full range of motion in joints
D.
E.
C.
Presence of osteophytes, subchondral osteoporosis
Local pain in the joints of normal x-ray pictures
169. Which of the following characteristic are true for the image that is shown in Fig.80?
A. * Movalis belongs to a group of nonspecific anti-inflammatory drugs and is used to treat rheumatic diseases
B. Movalis belongs to a group of salts of the gold and are used for the treatment of rheumatic diseases
Movalis belongs to a group of drugs of hinolon number, which are used to treat rheumatic diseases
D. Movalis belongs to a group of corticosteroids that are used for the treatment of rheumatic diseases

E.
170.
172.
Movalis belongs to a group of cytostatics, which are used for treatment of rheumatic diseases
Which of the following statements is true for the disease, displayed in Fig. 76?
A. *
E.
The most typical localization of lesions in rheumatoid arthritis joints - small joints of the hands, feet
B.
D.
The most typical localization of lesions of the joints in psoriasis - small joints of the hands, feet
C. The most typical localization of lesions of the joints of gout - small joints of the hands, feet
D. feet
A. *
The most typical localization of lesions in deforming arthritis of the joints - small joints of the hands,
E.
171.
The most typical localization of lesions of the joints in ankylosing spondylarthritis- small joints of the hands, feet
What damage of the pleura is most common in disease that is shown in Fig 76?
Dry, non exudatative pleuritis
Interparted pleuritis B.
C. Exudative pleuritis
Purulent bursed pleuritis
Pleuritis are not characterised
Which form of liver and gastrointestinal tract injury is more common in disease shown in Fig 76
A. *
B.
Intestinal amyloidosis
Atrophic gastritis
C.
D.
Erosive gastritis
Enteritis
E. Fatty liver
173.
A. *
Which of this following statements is true for the disease shown in Fig. 76
The most frequent localization of rheumatoid nodules – is in elbows
B. joints
The most frequent localization of rheumatoid nodules – in the inner surface of the interphalangeal
Most commonly the rheumatoid nodules are located in the achille tendon thickness C.
D. The most frequent localization of rheumatoid nodules – in the sternum, shoulder blades
What is the specific radiological signs in the first stage of disease shown in Fig 76 174.
A. * Osteoporosis

B.
C.
D.
E.
177.
C.
D.
E.
176.
A. *
B.
C.
D.
E.
175.
A.
B. *
E.
178.
A. *
B.
C.
A.
B.
C.
D. *
D.
E.
179.
Narrowing of joint slot, cyst-like
Cyst-like formations, markings on cartilage
Markings on cartilaginous surfaces, narrowing of the joint gaps
Ankylosis
What is the specific radiological signs in the second stage of disease shown in Fig 76
Osteoporosis, joint gap narrowing
Osteoporosis, joint gap narrowing, cyst-like formations
Markings on cartilaginous surfaces
Ankylosis
Cyst-like formations, markings on cartilage
What is the specific radiological signs in the third stage of disease shown in Fig 76:
Osteoporosis, cyst-like formations on cartilage
Osteoporosis
Cyst-like formations on the cartilage
Narrowing of joint gaps
Markings on the cartilage
What is the specific radiological signs in the fourth stage of disease, that is shown in Fig 76:
Osteoporosis
Markings on cartilage, cyst-like formations
Narrowing of joint gaps
Ankylosis, dislocated joints, markings in the cartilage
Markings on the cartilage, dislocated joints, cyst-like formations
What are the objective specific criteria of disease activity shown in Fig 76:
Articular index, hyperthermia, exudative effects
Articular index, duration of morning stiffness
The presence of joint fusion
The duration of morning stiffness
Pain
What are the subjective specific criteria of the disease activity, shown in Fig 76 RA:

A. *
B.
C.
D.
E.
180.
A. *
E.
181.
A.
B.
C. *
D.
B.
C.
D.
B. *
C.
D.
E.
183.
E.
182.
A.
A. *
B.
C.
D.
Complaints of pain, morning stiffness
The duration of morning stiffness
Articular index
Restrictions on movements in the joint
Exudative manifestations
What are the basic principles of the treatment of the disease shown in Fig 76:
Prevent progression with immunopathologic states
Prevention of disease with inflammation
Pain Therapy
Infection control
Psychotherapy
What are indications for using corticosteroids in diseases that appear in Fig 76
Combination of the disease with visceritis
Pseudoseptic process
The combination of SLE disease
Intolerance of crizanol
Slowly progressive RA
Which disease has such rentgenological picture as shoen in Fig 78?
Disease Foreste
Disease Bechterews
Metastatic lesion of the spine
Osteoporosis
Disease Kashyka-Bera
What is the pathology of bone, that is on the x-ray in Fig 77?
Osteoporosis
Osteomalacia
Osteosclerosis
Bone metastases

A.
B.
C.
D. *
E.
E.
F.
186.
185.
A.
B.
C. *
D.
E.
188.
A. *
187.
A. *
B.
C.
D.
E.
184.
A.
B. *
C.
D.
E.
Disease Kashyka-Bera
Which disease is represented in Fig 79
Gouty arthritis
Psoriatic arthritis
Reiter's disease
Rheumatic arthritis
Lipodystrophy
Which disease is represented in Fig 78
Gouty arthritis
Psoriatic arthritis
Bechterews disease
Reiter's disease
Rheumatic arthritis
Lipodystrophy
What is this X-ray symptom called in Fig.78?
Osteophytes of deforming osteoarthritis
Buchar nodules in rheumatoid arthritis
Heberden nodules in deforming osteoarthritis
Symptom "bamboo stick" disease Bechterews
Punches symptom of gout
In Fig.78, X-ray of the lumbosacral spine area shows which symptom?
"Bamboo stick"
Full bony ankylosis of the limits between vertebrates joints and iliac connections
Symmetric bone bridges that bind combinations between vertebral bodies.
Moderate bone atrophy
All listed
How is the disease called in Fig.79?
Psoriatic arthritis

B. Gouty arthritis
C. Rheumatoid arthritis
D.
E.
189.
A. *
Cancroid
Reiter's disease
To which group the drug in Fig. 80 belongs to?
Selective COG-2 inhibitors
B.
C.
Immunomodulators
Antibacterial drugs
D. Chondroprotectors
E. Glucocorticosteroids
190. To which group the drug in Fig. 81 belongs to?
A.
B. *
Selective COG-2 inhibitors
Immunosuppressant drugs
C. Antibacterial drugs
D. Chondroprotectors
E. Glucocorticosteroids
191.
A.
What are the indications for using the drug in Fig. 81?
Ankylosing spondyloarthritis
B. Psoriasis
C. Rheumatoid arthritis
D. Crohn's disease,
E. *
192.
All listed
What is the right dose of the drug in Fig. 81?
A. *
B.
The initial dose is 3 mg / kg. After 2nd and 6th weeks the mixture of remicade is introduced again.
The initial dose is 3 mg / kg. After 2nd and 6th days mixture of remicade is introduced again.
C. Initial dose of 1 mg / kg. After 2nd and 6th hours mixture of remicade is introduced again.
D.
E.
The initial dose is 3 mg / kg three times a day during first week. After 2nd and 6th weeks mixture of remicade is introduced again.
The initial dose is 3 mg / kg per day for a month. After 2nd and 6th months mixture of remicade is

B.
C. introduced again.
193. Which of the following statements is true for the drug in Fig. 81?
Remicade treatment should be held simultaneously with the use of methotrexate A. *
B. Remicade treatment should be held simultaneously with the use of antibiotics
Remicade treatment should be held simultaneously with the use of NSAIDs. C.
D. Remicade treatment should be held simultaneously with the use of chondroprotectives.
E. Remicade treatment should be held simultaneously with the use of B-vitamins
Which of these following statements is true for the drug in Fig. 81? 194.
A. Remicade - a compound based on hybrid mouse-and human IgG1 monoclonal antibodies
Remicade has high similarity with the tumor necrosis factor alpha B.
C. Remicade refers to a group of biological products
D. Remicade form neutralizes tumor necrosis factor alpha
All listed right E. *
195. Which manifestations of psoriatic arthritis is shown in Fig. 79?
Daktylitis A. *
B. Spondilitis
C. Entezyt
Serositis D.
E. "Symptom Punches"
What is the diagnostic sign of the disease in Fig.76? 196.
A. * Brush in the form of fin walrus
Heberden nodules
Buchar nodules
Atrophy of brush D.
E. Forest'e nodules
197. Which of this following statements is true for the disease, displayed in Fig.85?
Body temperature of patients with hypothyroidism increase to subfebril digits; A.
B. Body temperature of patients with hypothyroidism increase to febril digits;

C.
D.
E.
200.
A.
D.
E.
199.
A. *
B.
C.
D. *
E.
198.
A. *
B.
C.
201.
A.
B.
C.
D.
B.
C.
D. *
E.
E. *
202.
A.
Body temperature in patients with hypothyroidism is normal;
Body temperature in patients with hypothyroidism reduce .
Body temperature of patients with hypotireosis wavy (downgraded febril)
Which of this following statements is true for the disease, displayed in Fig.85?
Hypothyroidisms is characterized by the decrease of T3 and T4 and increase TSH
Hypothyroidisms is characterized by the decrease of T3, T4 and TSH;
Hypothyroidisms is characterized by the increase of T3, T4 and TSH decrease;
Hypothyroidisms is characterized by the increase of T3, T4 and TSH
Hypothyroidisms is characterized by the decrease of T3 and T4 increase.
Which of the following statements is true for the disease, displayed in Fig.85?
The main treatment of hypothyroidism is L-tyroxin
The main treatment of hypothyroidism is mercasolil
The main treatment of hypothyroidism is Iodomarin
The main treatment of hypothyroidism is prednisolone
The main treatment of hypothyroidism is Tyrozol
Which of this following statements is true for the disease, displayed in Fg.83?
Secondary hypothyroidism is characterized by a low level of corticotropin
Secondary hypothyroidism is characterized by a high level of thyroliberin
Secondary hypothyroidism is characterized by a low level of thyroliberin
Secondary hypothyroidism is characterized by a low level of thyrotropin
Secondary hypothyroidism is characterized by a high level of thyrotropin
What can you see in Fig.91?
Glucometer
Kaliper
Peak
Peakflowmeter
GlycaGen
What is the pathological condition in which GlycaGen ® HypoKit, shown in Fig.91 are used
Hepatic coma

A. *
B.
C.
D.
E.
206.
A. *
B.
C.
D.
E.
205.
B.
C.
D.
E.
C.
D.
E.
204.
A. *
B.
C.
D.
E. *
203.
A. *
B.
Thyrotoxic crisis
Hypertensive crisis
Hyperglycemia
Hypoglycemia
What are the symptoms of a disease in which GlycaGen ® HypoKit, shown in Fig.91 are used
Sweating, feeling of hunger, tremor, pallor
Face congestion, anorexia
Dry skin
Chest pain
Acetone smell from mouth
What is the level of glucose in the blood, in which GlycaGen ® HypoKit, shown in Fig.91 are used blood glucose levels below 2.5-3 mmol / l blood glucose above 3.5-4 mmol / l blood glucose above 4.5-5 mmol / l blood glucose above 5.5-6 mmol / l blood glucose above 6.5-7 mmol / l
What is the name of this device that is shown in Fig.94?
Glucometer
Kaliper
Peak
Paekflowmeter
GlycaGen ® HypoKit
What does this device measure? Fig.94
Blood glucose levels
Glucose in urine
Blood glucose
Glucose levels in saliva
Glucose sweating

207.
A.
Which of the following statements is true for the image shown in Fig.94?
The normal level of blood glucose, that was measured by this device is 2.2 - 3.3 mmol / l
B. * The normal level of blood glucose, that was measured by this device is 4.4 - 6.6 mmol / l
C. The normal level of blood glucose, that was measured by this device is 6.6 - 8.8 mmol / l
D. The normal level of blood glucose, that was measured by this device is 8.8 - 9.9 mmol / l
E.
208.
The normal level of blood glucose, that was measured by this device is 3.3 - 4.4 mmol / l
What is the immediate biomechanism of the drug that is shown in Fig. 93?
A. * Stimulation of production of thyroid hormones
B. Blocking the synthesis of thyroid hormones
C. Effect on osteogenesis
D.
E.
The influence of the developing of nervous system
Effect on basal metabolic
209. Which of this following statements is true for the image shown in Fig.85
A. The most common symptoms of hypothyroidism syndrome on ECG study is the heart beat
B. * The most common symptoms of hypothyroidism syndrome on ECG study is the low voltage
C.
D.
The most common symptoms of hypothyroidism syndrome on ECG study is paroxysmal tachycardia
The most common symptoms of hypothyroidism syndrome on ECG study is the high voltage
E.
210.
The most common symptoms of hypothyroidism syndrome on ECG study is the absence of pathological signs
Which of the following statements is true for the image shown in Fig.87?
A. A study of hormones in patients with hyperthyroidism diagnostic criterion is to increase T3, T4
B. A study of hormones in patients with hyperthyroidism diagnostic criterion is an isolated lower T3, T4
C. * A study of hormones in patients with hyperthyroidism diagnostic criterion is to increase T3, T4 and
TSH decrease
D. A study of hormones in patients with hyperthyroidism diagnostic criterion is the reduction of T3, T4 and TSH increase
E. A study of hormones in patients with hyperthyroidism diagnostic criterion is the TSH level fluctuations
211. mean?
In pathology, that is shown in Fig. 87 the diagnostic feature is the Dalrimple symptom. What does it
A. Symptom of Dalrimple: increased eye gloss

B. *
C.
Symptom of Dalrimple: internal expansion slot with the advent of the white band between the sclera and iris upper eyelid
Symptom of Dalrimple: wet blinking by eyelids, exophthalmos
D. Symptom of Dalrimple: trembling of the closed eyelids
E. Symptom of Dalrimple: violation of convergence of eyeballs
212. mean?
In pathology, that is shown in Fig. 87 the diagnostic feature is the Kraus symptom. What does it
A. * Symptom of Kraus: increased eye gloss
B. : Symptom of Kraus: staring internal slit
C. Symptom of Kraus: wet blinking by eyelids, exophthalmos
D. Symptom of Kraus: tremor of closed eyelids
E. Symptom of Kraus: violation of convergence of eyeballs
213. mean?
In pathology, that is shown in Fig. 88 the diagnostic feature is the Shtelvag symptom. What does it
A. Shtelvag Symptom: increased eye gloss
B.
C. *
ShtelvagSymptom: staring internal slit
ShtelvagSymptom: wet blinking by eyelids, exophthalmos
D.
A.
Shtelvag Symptom:, small tremors
E. Shtelvag Symptom: violation of convergence of eyeballs
214. mean?
In pathology, that is shown in Fig. 88 the diagnostic feature is the Rozenbah symptom. What does it
High gloss eye
Staring internal slit B.
C. Liquid blink
D. *
E.
B. *
Fine trembling of the closed eyelids
Violation of convergence eye balls, eye pigmentation
215. mean?
In pathology, that is shown in Fig. 88 the diagnostic feature is the Elinek symptom. What does it
A. Symptom of Elinek: increased eye gloss
Symptom of Elinek: pigmentation around the eyes
C. Symptom of Elinek: continuous wet eye blink

D.
E.
C.
Symptom of Elinek: fine trembling in closed eyelids
Symptom of Elinek: pigmentation all over
216. mean?
In pathology, that is shown in Fig. 87 the diagnostic feature is the Moebius symptom. What does it
Moebius Symptom: violation convergence eyeballs A. *
B. Moebius Symptom: increased eye gloss
Moebius Symptom: Eye pigmentation
Moebius Symptom: Continuous wet eye blinking D.
E. Moebius Symptom: fine trembling during the closed eyelids
Which of this following statements is true for the image shown in Fig. 85? 217.
A. * Hypothyroidism is characterized by bradycardia
B. Hypothyroidism is characterized by tachycardia
C.
D.
E.
Hypothyroidism is characterized by hirsutism
Hypothyroidism is characterized by limb hyperkinesis
Hypothyroidism is characterized by all mentioned
218. Which of this following statements is true for the image shown in Fig. 88?
A.
B. *
Hyperthyroidism is characterized by bradicardia
Hyperthyroidism is characterized by tachycardia
C. Hyperthyroidism is characterized by hirsutism
D. Hyperthyroidism is characterized by hyperkinesis
E. Hyperthyroidism is characterized by all mentioned
219. What is the mechanism of action of the drug, shown in Fig. 99
A. * action
Milhama is a neurotropic vitamins of group B, which exerts anti-inflammatory and antidegenerative
B. Milhama has a lipid lowering effect
C. Milhama is an antagonist of insulin and hypoglycemic and has an antispasmodic action
D. Milhama shows
antibacterial activity
E. Milhama is an analogue of the natural thyroid hormone

220. What is the mechanism of action of the drug, that is shown in Fig.100
A. action
Glucofaz is a neurotropic vitamins of group B, which exerts anti-inflammatory and antidegenerative
B. Glucofaz has a lipid lowering effect
C. * Glucofaz is an antagonist of insulin and hypoglycemic and has an antispasmodic action
D. Glucofaz shows antibacterial activity
E.
221.
Glucofaz is an analogue of the natural thyroid hormone
What is the mechanism of action of the drug, that is shown in Fig.93
A. action
Ksenikal is a neurotropic vitamins of group B, which exerts anti-inflammatory and antidegenerative
B. *
C.
Ksenikal has hypolipidemic effect
Ksenikal is an antagonist of insulin and hypoglycemic and has antispasmodic action
D. Ksenikal shows antibacterial activity
E.
222.
223.
Ksenikal is an analogue of the natural thyroid hormone
What is the mechanism of action of the drug, that is shown in Fig. 93
A.
B.
L-thyroxin-containing neurotropic vitamins of group B, which exerts anti-inflammatory and antidegenerative action
L-thyroxin has lipid lowering effect
C. L-thyroxin is an antagonist of insulin and hypoglycemic and has antispasmodic action
L-thyroxin shows antibacterial activity D.
E. * L-thyroxin is the analogue of the natural thyroid hormone
Which of this following statements is true for the disease, displayed in Fig. 85?
The main drug used to treat hypothyroidism is L-thyroxin A. *
B. The main drug used to treat hypothyroidism is mercasolil
The main drug used to treat hypothyroidism is Iodomarin C.
D. The main drug used to treat hypothyroidism is prednisolone
The main drug used to treat hypothyroidism is Thyrozol E.